Pharmacovigilance is rapidly evolving in response to the dynamic landscape of healthcare, regulatory demands, and technological advancements. As the healthcare industry shifts toward more personalized and tech-enabled solutions, the role of pharmacovigilance becomes increasingly critical in safeguarding patient health and ensuring the continued efficacy and safety of therapeutic products. Adapting […]
Pharmacovigilance (PV) is defined as the science associated with monitoring and assessing the safety, efficacy and quality of drugs through pre-marketing and post-marketing surveillance. The main focus is to identify adverse effects that may arise from several pharmaceutical products. This process should be conducted throughout the entire lifecycle of the […]
Clinical Trials on Antibody–drug conjugates (ADCs) are gaining significant attention as a promising class of targeted anticancer therapies. The journey of ADCs began with Mylotarg, developed by Pfizer, which received its first regulatory approval in 2000. However, concerns related to safety led to its withdrawal a decade later. Its subsequent […]